Cosmos Pharmaceuticals, Inc.

CIK 1845816 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cosmos Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Oct 7, 2025D0001845816-25-000003
Jun 3, 2022D0001567619-22-012225
Feb 23, 2021D0001567619-21-004653